FIRMQUARRYResearch workspace

UK_FTS process · buyer country GB · planning

NHS National Framework for Macitentan tablets

NHS England

Procedure ocds-h6vhtk-0668c2CPV 33600000Healthcare
GBP 128,400,000
Data last updated Oct 22, 2026 · Source: Find a Tender OCDS
Buyer identifier
GB-PPON: PDPT-3135-BWWY
Primary supplier
Not reported
Procurement method
Not reported
Tender deadline
Not reported
Contract period
Not reported — Not reported
Native value
GBP 128,400,000
USD comparison
Not shown — no auditable FX observation
Official source
Open notice ↗

Description

Project title: NHS National Framework Agreement for Macitentan & Cladribine Tablets Offer reference number: CM/TNS/26/5748 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. CM/TNS/26/5748/01 Macitentan Lot 1 DCE/DLN: 01/10/2027 to 30/09/2029 (24 months) CELN Lot 2 DNW/DLS: 01/10/2027 to 31/01/2029 (16 months) NWLS Lot 3 DNE/DSW: 01/10/2027 to 30/09/2029 (24 months) NESW CM/TNS/26/5748/02 Cladribine Tablets Lot 1 DCE/DSW: 01/10/2027 to 30/09/2029 (24 months) CESW Lot 2 DLN/DNW: 01/10/2027 to 31/01/2029 (16 months) NWLN Lot 3 DLS/DNE: 01/10/2027 to 30/09/2028 (12 months) LSNE Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Suppliers

    Official lifecycle

    Process timeline

    1. Source update

      NHS National Framework Agreement for Macitentan & Cladribine Tablets

      GB · uk_find_a_tenderGBP 128,400,000Source ↗
    2. Planned

      NHS National Framework for Macitentan tablets

      GB · uk_find_a_tenderGBP 128,400,000Source ↗

    Auditable model output

    Predictive intelligence

    Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

    Append-only source history

    Source records

    RecordDateStagesFetched
    104326-2026Nov 3, 2026planningUpdateNov 3, 2026
    104267-2026Nov 3, 2026planningNov 3, 2026